Functional Disorders of the Musculoskeletal System in People With Mult
Evaluation of the Effect of the Physiotherapy on Mobility and Functional Disorders of the Musculoskeletal System in People With Multiple Sclerosis
What it found
We found no results in the registry or in papers.
This trial finished 8 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Manual physiotherapeutic correction (MFK) Method
- Dynamic Neuromuscular Stabilization (DNS) Method
What it measured
Main measures
Timed Up and Go (TUG)
six months
Walking and mobilityBerg Balance Scale (BBS)
six months
Walking and mobilityDynamic Gait Index (DGI)
six months
Walking and mobilityFive times Sit to Stand test (5STS)
six months
2-Minute Walk Test (2MWT)
six months
Walking and mobilitySymbol Digit Modalities Test (SDMT)
six months
Thinking and memoryFour Square Step Test (FSST)
six months
Other measures (6)
Questionnaires - The Fatigue scale for motor and cognitive functions (FSMC)
six months
Thinking and memoryFatigueQuestionnaires -Multiple Sclerosis Impact Scale (MSIS-29)
six months
Quality of life (reported by participants)Questionnaires - Euroqol-5 dimensions-5 levels health questionnaire
six months
Walking and mobilityPainMood and sleepQuality of life (reported by participants)Questionnaires -Multiple Sclerosis Walking Scale-12 (MSWS-12)
six months
Walking and mobilityQuestionnaires - Rivermead Mobility (RMI)
six months
Walking and mobilityQuestionnaires- Activities-specific Balance Confidence Scale (ABC)
six months
Walking and mobility
Who could take part
MS (type not specified) · 18 to 70
Show the full criteria
Inclusion criteria
* exact diagnosis of MS stated by neurologist * Expanded Disability Status Scale (EDSS) ≥ 2 and ≤ 6,5 * no previous physiotherapy in six months * no clinical relapses and changes in pharmacotherapy in the previous month or during the rehabilitation trial * ability to undergo ambulatory physiotherapy
Exclusion criteria
* other neurological disease or conditions disabling movement (e.g. stroke, pregnancy, fracture)
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The randomized controlled trial is aimed to study the efficacy of treatment approaches based on developmental kinesiology models and its impact on balance, gait and mobility in people with mild to severe multiple sclerosis (pwMS). The main goal is to compare two out-patient physiotherapeutic methods, that will be attended 1-hour twice a week for one month and once a week for next two months (16 therapies in total). The efficacy will be assessed by a blinded independent clinical examiner using clinical examination and questionnaire survey one month before the therapy programme, immediately before and after the therapy and two months after termination of the therapy.
Loading reviews and guidelines…
History
Started
May 2016
Main results due
May 2018
Finished
Dec 2020